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Considering the high prevalence of human cervical cancer and the adverse effects of the available 
treatments, it is important to develop studies involving plants. Eugenia uniflora L. is a Brazilian native 
plant widely used in folk medicine and some biological effects have already been described. In this study, 
we investigated the biologicals effects of the aqueous crude extract of E. uniflora leaves in relation to the 
viability of human cervical cancer cells (SiHa), non-tumorigenic cells HaCaT and human lymphocytes. 
Our results demonstrated that different concentrations of E. uniflora’s extract significantly inhibited the 
viability of the Siha cell line at 24, 48 and 72 hours of treatment, but did not induce significant changes 
in the HaCat cell line and human lymphocytes. Tumor cells had adhesion capacity, migration processes, 
ability of colony forming and the potential to recover its viability after treatment. withdrawal, significantly 
reduced. The nuclear morphology revealed chromatin condensation, and the flow cytometry showed 
predominantly cell death by apoptosis in the treated tumor cells. Therefore, the E. uniflora’s extract may 
contribute for future studies aiming at new therapeutic perspectives for human cervical cancer.
Keywords: Eugenia uniflora L./effects/antitumoral. Pitangueira. SiHa. HaCat. Plant extract/antitumoral. 
Cervical cancer.
INTRODUCTION
Cervical cancer remains a disease of high prevalence, 
incidence, and mortality, and it is the fourth most common 
cancer in women and the seventh overall (Siegel, Miller, 
Jemal, 2016). In developing countries such as Brazil, this 
pathology has maintained high levels of incidence, (with 
an increase of 29% comparing the last two decades) and 
thus it is the fourth cause of cancer death in women in 
Brazil (Brasil, 2015). Squamous cell carcinoma accounts 
for approximate 80% of cervical carcinoma, whereas 
adenocarcinoma is less common and accounts for 20% of 
cervical carcinoma (Parkin, Bray, 2006). Cervical cancer 
occurs in people of all ages, including relatively young 
age groups, and sexual transmission of human papilloma 
virus (HPV) is the major etiological factor (Walboomers 
et al., 1999).
Unfortunately, the data indicates increased long-
term risk for invasive cervical cancer in women after 
treatment of cervical intraepithelial neoplasia (Soutter, 
Sasieni, Panoskaltsis, 2006) and a high recurrence rate 
of cervical cancer after radical hysterectomy (Mabuchi, 
Kozasa, Kimura, 2017).
For these reasons, many studies based on plant have 
been seeking antiproliferative or cytotoxic activities for 
tumor cells, in search of new antineoplastic agents.
Eugenia uniflora L., Myrtaceae, is a plant widely 
found in Brazil, Argentina, Paraguay and Uruguay 
(Lima, Mélo, Lima, 2005). Infusions or decoctions 
made from the leaves of this plant are commonly used 
in folk medicine as antidiarrheic, diuretic, antirheumatic, 
antihypertensive, astringent, antipyretic, and for the 
treatment of digestive disorders (Bandoni et al., 1972; 
Fiuza, Rezende, Sabóia-Morais, 2008). Previous studies 
demonstrated that leaf extracts of Eugenia uniflora were 
slightly active on lipid metabolism, exerted a protective 
effect on triglycerides and very low-density lipoprotein 
levels (Ferro et al., 1988) and had a highly significant 
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anti-inflammatory action (Schapoval et al., 1994). 
Consolini and Sarubbio (2002) showed that the aqueous 
crude extract of E. uniflora leaves had a hypotensive 
effect mediated by direct vasodilation and diuretic 
activity. Other biological effects have been described 
in the literature, such as antioxidant (Lima, Mélo, 
Lima, 2002), antimicrobial (Bouzada et al., 2009) and 
hypoglycemic (Lee et al., 2000).
The phytochemical screening of the leaves 
demonstrated the presence of flavonoids, triterpenes 
and saponins (Alice et al., 1991). Others studies also 
proved this composition and identified the presence 
of tannins, triterpenes, anthraquinoneheterosides and 
steroids (Fiuza, Rezende, Sabóia-Morais, 2008). Plants 
rich in tannins are used in the traditional medicine to 
treat diarrhea, hypertension, rheumatism, bleeding, 
wounds, burns, stomach problems, kidney and urinary 
tract problems and inflammatory processes in general 
(Simões, 2006). Polyphenolic compounds like flavonoids 
have an enormous range of biological actions that 
include anti-inflammatory, antiallergenic, antiviral, 
antibacterial, antifungal, antitumor and antihemorrhagic 
(Formica, Regelson, 1995; Slowing, Carretero, Villar, 
1994). Furthermore, in a previous study leaf extracts 
of E. uniflora have shown antioxidant activity, and 
polyphenolic compounds are implicated in this activity 
(Reynertson, Basile, Kennelly, 2005). Despite these 
researches, there are no reports describing the possible 
antitumor effects of E. uniflora on cervical cancer cells. 
Therefore, in this study we intend to investigate the 
biological effects of aqueous crude extract from leaves of 
E. uniflora in relation to the viability of human cervical 
cancer cells, as well as verify if this extract affects the 
viability of non-tumorigenic cells. 
MATERIAL AND METHODS
Material
Penicillin/gentamicin, fungizone (amphotericin B) 
and fetal bovine serum (FBS) were purchased from Gibco 
(Gibco BRL, Grand Island, NY). Dulbecco’s modified 
Eagle’s medium (DMEM), RPMI-1640, trypsin/EDTA 
solution, Trypan Blue dye, Hoechst® 33258 stain, Ficoll 
(Histopaque®) and MTT (3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl tetrazolium bromide) were purchased 
from Sigma Aldrich (St. Louis, MO, USA). Annexin V 
Apoptosis Detection Kit was purchased from Santa Cruz 
Biotechnology, Inc, Santa Cruz, CA. All other chemicals 
and solvents used were of analytical grade.
Plant material
Leaves of E. uniflora were collected and botanically 
identified, washed, disinfected with sodium hypochlorite 
2% and then washed with deionized water. The vegetal 
material was dried in incubator at 60 °C for 3 days, and 
after dehydration, the leaves were crushed. The powder 
was dissolved in DMEM medium, heated to 40 °C under 
stirring for 1 hour. The solution was then centrifuged at 
2,000 rpm for 20 minutes and the supernatant was filtered 
with a membrane filter (0,22 µm), and used in the different 
assays. 
Cell lines maintenance
The human cell line derived from invasive cervical 
carcinoma, SiHa (HPV 16-positive) was obtained from 
American Type Culture Collection (ATCC - Rock-Ville, 
MD) and the immortalized human keratinocytes, HaCaT, 
were kindly donated by Dr. Luisa L. Villa (ICESP, School 
of Medicine, University of São Paulo) and Dr. Silvya 
S. Maria-Engler (School of Pharmaceutical Sciences, 
University of São Paulo). Cell lines were cultured in 
DMEM supplemented with 10% FBS, 100 μg/mL 
streptomycin and 0.5 μg/mL fungizone. The cell culture 
was maintained at 37 °C in 5% CO2 atmosphere.
Human lymphocytes culture 
Human lymphocytes were used as non-tumorigenic 
cells control for the investigation of toxic effects on 
normal cells. For this, human peripheral blood was diluted 
with RPMI and centrifuged with Ficoll (Histopaque®). 
After, the fraction enriched with mononuclear cells were 
centrifuged for washing, counted and plated for further 
assays. The cells were maintained in 5% CO2 incubator at 
37 °C with RPMI-1640 medium supplemented with 10% 
FBS, 100 μg/mL streptomycin and 0.5 μg/mL fungizone.
Cell viability analysis 
The viability of SiHa and HaCat cells was determined 
using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide) assay. Briefly, suspensions of cells 
were seeded in 96-well plates at densities of 2.8 ×10³ cells/
well and maintained to grow to confluence in incubator 
at 37 °C in 5% CO2. After cell adhesion, the supernatant 
was aspirated and the cells were treated with the aqueous 
crude extracts at different concentrations (0.5, 1.5, 2.5, 5, 
10, 15 and 20 mg/mL) for 24, 48 and 72 hours. Controls 
were prepared using only DMEM medium. 
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After withdrawn treatment, MTT solution (0.5 mg/
mL) was added to each well and plates were incubated 
for 3.5 hours at 37 °C. Formazan crystals formed by 
tetrazolium cleavage were dissolved with Dimethyl 
Sulfoxide (DMSO) and quantified at 570 and 630 nm using 
an EnVision Multilabel Plate Reader (PerkinElmer). The 
results were expressed as percentage of control, which 
was considered as 100% of cell viability. IC50 values were 
calculated from log dose-response curves using GraphPad 
Prism 5 software.
In order to analyze the viabili ty of human 
lymphocytes, these cells were seeded in a 96-well plate 
(8 × 103 cells/well) and maintained in an incubator at 
37 °C in 5% CO2. The cells were treated with the different 
concentrations of extract (0.5, 1.5, 2.5, 5, 10, 15 and 
20 mg/mL) for 24 hours. Then, the suspension of cells was 
diluted with Trypan Blue (1:1 v/v) to selectively stain dead 
cells, and viable cells (trypan blue negative) were counted 
by Neubauer chamber in an optical microscope. Controls 
were prepared using only RPMI medium.
Wound healing assay
The cell migration was measured using the wound 
healing assay as described by Rodriguez, Wu and Guan 
(2005). Briefly, SiHa cells were seeded in 24-well plates 
(2.8 x 104 cells/well) and grown to confluence. The 
confluent cell monolayer was carefully wounded using 
a pipette tip. Then, the cellular debris were removed by 
washing with PBS and the wounds were photographed 
before and after treatment with extract at IC50 (7.8 mg/
mL) concentration. The cell migration into the scratched 
region was recorded using an Olympus CK40 microscopy 
system coupled to an UCMOS 03100 KPA digital camera 
before treatment, and then 24 and 48 hours after treatment. 
The cells that migrated across the reference line in treated 
and control dishes were counted and averaged. The results 
were calculated by comparing the wound width before and 
after treatment in treated and control dishes.
Adhesion assay
SiHa cells were plated (2.8 × 104 cells/well) in 24-
well plates and immediately treated with crude extract of 
E. uniflora at 5, 10 and 20 mg/mL for 24 hours. After this 
period, aliquots of cellular suspension from each well were 
removed and mixed with trypan blue dye exclusion for 
counting of unadhered viable cells using hemocytometer. 
Results were expressed as the number of viable treated 
cells which had not adhered in comparison with the 
control.
Clonogenic assay
The clonogenic ability following treatment with 
crude extract of E. uniflora in cancer cells was performed 
by using clonogenic assay as described by Franken et 
al. (2006). For this purpose SiHa cells (2.8 × 104 cells/
well) were seeded in a 24-well plate and after adhesion, 
the subconfluent cultures were treated with an extract at 
IC50 (7.8 mg/mL) for 24 hours. The adherent cells from 
treated and control dishes were then washed with PBS, 
trypsinized, counted in hemocytometer, and replated 
in six-well plates (100 cells/well). After 10 days of 
incubation, the formed colonies were stained with crystal 
violet after fixation with methanol and counted manually. 
The results were expressed as survival fraction, which 
was obtained by dividing the number of colonies that arise 
after treatment by the number of cells seeded and plate 
efficiency (PE: number of colonies formed by untreated 
cells/number of cells seeded), multiplied by 100 (Franken 
et al., 2006).
Washout assay
The recovery capacity after withdrawal of treatment 
was determined by Washout Assay. SiHa cells (2.8 × 
104 cells/well) were seeded in a 24-well plate and after 
adhesion, the subconfluent cultures were treated with an 
extract at IC50 (7.8 mg/mL) concentration for 24 hours. 
The adherent cells were then washed with PBS to remove 
the entire treatment, trypsinized, counted and replated 
in 96-well plates (2.800 cells/well). After that, the cells 
were incubated for 4 days at standard conditions, and the 
MTT assay was used to measure cell viability as described 
before (Cell Viability Analysis section).
Hoechst stain
The morphological changes occurring during 
apoptosis were evaluated using the fluorescent Hoechst® 
33258 stain. SiHa cells (2.8 × 104 cells/well) were seeded 
in a 24-well plate containing glass coverslips. After 
adhesion, the cells were treated with aqueous crude extract 
of leaves of E. uniflora at concentration of 7.8 mg/mL (IC 
50) for 24 hours. Afterwards, the cells were washed with 
PBS and fixed with paraformaldehyde 4% for 20 minutes. 
The cells were then stained with Hoechst® 33258 (1µg/
mL) for 20 minutes at room temperature. The coverslips 
were removed for blade mounting and cell morphology 
analysis. Photography was obtained using fluorescence 
microscope BIOVAL- L2000A coupled to an OPTON 
digital camera.
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Annexin V /Propidium iodide staining
The phosphatidylserine externalization was 
determined by the annexin fluorescence signal of an 
annexin V–fluorescein isothiocyanate conjugate (Santa 
Cruz Biotechnology, Inc, Santa Cruz, CA) according 
to the manufacturer’s protocol. SiHa cells were treated 
for 24 and 48 hours with aqueous crude extract of E. 
uniflora, trypsinized and centrifuged at 1600 rpm. The 
pellet was resuspended with annexin binding buffer (10 
mM 4-(2-hydroxyethyl)-1-piperazine ethanosulfonic 
acid, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2), incubated 
with annexin V and PI at room temperature in the dark 
and analyzed on a Guava EasyCyte flow cytometer, 
using Guava EasyCyte software for analysis (Millipore, 
Billerica, MA).
Statistical analysis
All of the values were expressed as averages and 
standard deviation (SD) from at least three independent 
experiments performed in triplicate. The data was 
analyzed using one way analysis of variance (ANOVA) 
followed by the Tukey test using the GraphPad Prism 
5 (San Diego, USA, 2007). Statistical differences were 
considered significant when the value was p < 0.05.
RESULTS
E. uniflora aqueous crude extract promotes 
cancer cell death 
Parameters such as concentrations and treatment 
times were standardized using a cell viability assay with 
different concentrations (from 0.5 mg/mL to 20 mg/mL) 
of the aqueous crude extract obtained from the leaves of 
E. uniflora in human cervical cancer cells (SiHa).
Throughout the MTT assay it was observed that 
different concentrations of the aqueous crude extract 
significantly inhibited the viability of SiHa cells in relation 
to the control in all the three times tested. At 24 hours 
of treatment, the inhibition was between 17% and 41% 
(Figure 1A); at 48 hours of treatment, it was between 
35% and 65% (Figure 1B), and at 72 hours of treatment, 
it was between 11% and 61% (Figure 1C). Based on 
the cell viability tests, it was possible to obtain the half 
maximal inhibitory concentration (IC50) of 7.8 mg/mL 
for the aqueous crude extract in SiHa cell line at 24 hours 
of treatment.
In contrast, the different concentrations of the 
aqueous crude extract of E. uniflora induced an increase 
of cell viability until 10 mg/mL and a cytotoxic effect at 
15 and 20 mg/mL in the non-tumor cells used (HaCaT) at 
FIGURE 1 - Effects of treatment with different concentrations 
of E. uniflora aqueous crude extract in relation to the viability 
of cervical carcinoma cells (SiHa) for 24 hours (A), 48 hours 
(B) and 72 hours (C). Data show mean and standard deviation 
of 3 independent experiments performed in triplicate. * P <0.05 
(One-way ANOVA followed by Tukey’s test).
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24 hours of treatment (Figure 2A).
We also tested the aqueous crude extract of E. 
uniflora to verify cytotoxicity in primary cultures of human 
lymphocytes as a non-tumor control using concentrations 
between 0.5 and 20 mg/mL. The results demonstrated that 
treatment did not inhibit significantly the lymphocytes 
viability when compared to control in most of the different 
concentrations tested (Figure 2B).
E. uniflora aqueous crude extract affects cell 
migration and adhesion 
Apart from the observed inhibition on the cell 
viability, the investigation of the aqueous crude extract 
of E. uniflora effects in relevant indicators for SiHa cells 
also demonstrated significant results.
The Wound Healing method was performed to 
determine the rate of cell migration. This method is based 
on the observation that, upon creation of a “wound” on 
a confluent cell monolayer, the cells on the edge of this 
wound will move toward the opening until new cell-cell 
contacts are established again (Liang, Park, Guan, 2007).
In Figure 3A we can observe a picture of the wounds 
in the cell monolayer before and after the treatment. The 
tumor cells had their migration process significantly 
reduced after treatment with the E. uniflora aqueous crude 
extract (7.8 mg/mL) at 24 hours (for 63.4%) and at 48 
hours (for 24.5%) as seen in Figure 3B.
The tumor cell-adhesion capacity was also 
significantly inhibited by the treatment with E. uniflora 
aqueous crude extract in the different tested concentrations. 
It was observed an increase in the number of unadhered 
viable cells while increasing extract concentration 
determining a dose-dependent relation (Figure 3C).
Clonogenic ability and capacity to regrow after 
treatment exposure are impaired
Another significant parameter to evaluate the effect 
of a treatment on cancer cells is the colony-forming 
capacity. Clonogenic assay is a method used to determine 
the fraction of seeded cells that retain the capacity to 
produce colonies and, for this reason, it is useful to 
determine the effectiveness of cytotoxic agents (Franken 
et al., 2006; Mello et al., 2014)
Figure 4A shows that the treatment markedly 
reduced the number of colonies formed in relation to 
control. These results were quantified and revealed that 
the treatment with the E. uniflora aqueous crude extract 
at 7.8 mg/mL for 24 hours was able to significantly inhibit 
the number of colonies formed for 81%, and thus, the 
clonogenic capacity of SiHa cells (Figure 4B).
To determine the persistence of the effects of 
treatment exposure in cancer cells, we evaluated the cell 
viability after the removal of the extract.
In Figure 4C it was also possible to observe that only 
2% of the treated cells were able to recover the viability 
even after the removal of the treatment with E. uniflora 
aqueous crude extract.
Cell death induced by E. uniflora aqueous crude 
extract shows features of apoptosis 
The analysis of nuclear morphology was performed 
using fluorescent dye Hoechst® 33258. The results showed 
a fluorescence increase in the treated SiHa cells pointing 
out a greater chromatin condensation and, therefore, a 
FIGURE 2 - (A) Effect of treatment with different concentrations 
of E. uniflora aqueous crude extract in relation to the viability 
of immortalized human keratinocytes cell line (HaCaT) for 
24 hours. (B) Effect of treatment with different concentrations 
of E. uniflora aqueous crude extract on the viability of human 
lymphocytes for 24 hours. Data show mean and standard 
deviation of 3 independent experiments performed in triplicate. 
* P <0.05 (One-way ANOVA followed by Tukey’s test).
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possible cell death via apoptosis (Figure 5A). The data 
obtained through flow cytometry and double staining for 
annexin V/ propidium iodide showed that 1.39% of the 
tumor cells were marked for annexin V after 24 hours and 
40.06% after 48 hours of treatment, while 3.44% of the 
tumor cells were marked for propidium iodide after 24 
hours of treatment and 1.33% after 48 hours (Figure 5B). 
It determines a predominantly cell death by apoptosis in 
the tumor cells treated for 48 hours with the E. uniflora 
aqueous crude extract.
FIGURE 3 - Representative pictures (A) and measurement 
(B) of the effect of E. uniflora aqueous crude extract (7.8 mg/
mL) on the migration capacity of SiHa cells after 24 and 48 
hours of treatment. Data show mean and standard deviation of 
3 independent experiments performed in triplicate. * P <0.05: 
statistically different in relation to control before treatment (C0), 
** P <0.05: statistically different in relation to control after 24 
hours (C24), # P <0.05: statistically different in relation to control 
of treatment (CT) (One-way ANOVA followed by Tukey’s 
test). (C) Effect of treatment with different concentrations of 
E. uniflora aqueous crude extract on the adhesion capacity of 
SiHa cells for 24 hours. Results were expressed as the number 
of viable treated cells which were not adhered in comparison 
with the control. Data show mean and standard deviation of 3 
independent experiments performed in triplicate. * P <0.05 in 
relation to control, # P < 0.05 in relation to 5 mg/mL (One-way 
ANOVA followed by Tukey’s test).
FIGURE 4 - Representative pictures (A) and measurement (B) 
of the effect of E. uniflora aqueous crude extract (7.8 mg/mL) on 
the clonogenic capacity of SiHa cells for 24 hours of treatment. 
(C) Analysis of the cell viability through the washout assay 
after 24 hours of treatment with the E. uniflora aqueous crude 
extract (at 7.8 mg/mL). Data show mean and standard deviation 
of 3 independent experiments performed in triplicate. * P <0.05 
(One-way ANOVA followed by Tukey’s test).
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DISCUSSION
Plant-derived compounds have been an important 
source of several clinically useful anti-cancer agents. In 
this study we observed that treatment with the aqueous 
crude extract obtained from the leaves of E. uniflora was 
able to change many relevant cell parameters for growth, 
expansion and survival of human cervical cancer cells. 
Different concentrations of the aqueous crude extract of 
E. uniflora significantly inhibited the viability of human 
cervical cancer cells at 24, 48 and 72 hours of treatment, 
but did not inhibit the viability of both non-tumor cells 
tested (immortalized human keratinocytes – HaCaT and 
primary cultures of human lymphocytes). These results 
are encouraging, since a balance between therapeutic 
versus toxicological effects of the compound is important 
when determining its applicability as a pharmacological 
alternative. In addition to that, a number of promising 
new agents are in clinical development based on the 
selective activity against cancer-related molecular targets. 
Nevertheless, it is known that one major challenge in 
anticancer therapy is to increase the selectivity of current 
treatments against cancer cells in order to spare normal 
cells.
With regard to our results, the real targets of the 
constituents of E. uniflora plant extract in tumoral cells 
must be specified in future studies. Since, chemical 
investigation showed quercetin as the major components 
of E. uniflora leaves (Rattmann et al., 2012), in this study 
human cervical cancer cells were treated with different 
concentrations of this flavonoid (data not shown). 
However, this treatment did not induce significant changes 
on the viability of the tested tumor cells, demonstrating 
that our results cannot be attributed to quercetin. Even 
so, it is still necessary to test other molecules already 
described in the composition of this plant species. 
However, the contribution of different molecules 
that acting synergistically to the observed biological 
effects cannot be ruled out. The use of ‘whole extract 
versus single-isolated constituent’ has been an issue of 
ongoing debate the past several years. In addition to this, 
accumulating evidence show the existence of synergistic 
interactions among phytochemicals.
The benefits of E. uniflora are usually attributed 
to the presence of many secondary metabolites present 
in the leaves, which include many volatile terpenoid 
oils, flavonoids, and condensed and hydrolysable 
tannins, leucoanthocyanidins, and steroids and/or 
triterpenoids (Amorim et al., 2009). Flavonoids presented 
in many plant extracts, have been constantly the focus of 
pharmacological studies, especially by antioxidant effects 
already demonstrated (Cacciola et al., 2007). It is known 
that damaging free radicals and reactive oxygen species 
(ROS) produced naturally through oxidative metabolism 
have also been linked to some cancers (Jacob, Burri, 
1996).
In addition to effects on cell viability, the treatment 
with the aqueous crude extract from E. uniflora induced 
significant effects on relevant indicators for human 
cervical cancer cells, such as inhibition of the adhesion 
and migration processes of these cells. We verified the 
cell migration by using Wound Healing assay that is 
a simple method, inexpensive, capable of evaluating 
the cell migration by cell interaction with extracellular 
matrix and cell-cell interactions, and mimics to some 
extent the migration of cells in vivo (Liang, Park, Guan, 
2007).
FIGURE 5 - (A) Analysis of nuclear morphology in fluorescence 
microscope using Hoechst® 33258 dye (at 1 μg/mL) in SiHa 
cells treated with the E. uniflora aqueous crude extract (at 7.8 
mg/mL) for 24 hours. (B) Flow cytometry analysis of the cell 
death mechanism by the labeling with annexin V / propidium 
iodide in SiHa cells treated with the E. uniflora aqueous crude 
extract (at 7.8 mg/mL) for 24 and 48 hours.
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It is known that, cell migration is a fundamental 
feature of the interaction of cells with their surroundings. 
Migration of tumor cells has been extensively studied due 
to its importance in the process of metastasis (Yamaguchi, 
Wyckoff, Condeelis, 2005).
Metastasis is also facilitated by cell-cell interactions 
between tumor cells and the endothelium that contribute to 
tumor cell adhesion, extravasation, and the establishment 
of metastatic lesions (Bendas, Borsig, 2012). Some 
families of cell adhesion molecules such as selectins and 
integrins have been identified as participants in metastasis 
(Paschos, Canovas, Bird, 2009) and may be important 
targets of the components present in the plant extract used.
Considering that adhesion and migration of 
cancer cells play a critical role in the metastatic cascade, 
inhibition of these processes may represent targets for 
therapeutic strategies focused on developing not only 
tumors, but also metastases.
Furthermore, our results by using clonogenic assay 
showed that the treatment with E. uniflora aqueous crude 
extract was able to significantly inhibit the colony-forming 
capacity of tumor cells. The Clonogenic cell survival assay 
determines the ability of a cell to proliferate indefinitely, 
thereby retaining its reproductive ability to form a large 
colony or a clone. Clonogenic assay is the method of 
choice to determine cell reproductive death after treatment 
with ionizing radiation, but can also be used to determine 
the effectiveness of other cytotoxic agents (Franken et 
al., 2006).
When treated viable cells were seeded after 
withdrawal of the treatment, they were unable to 
recover their viability, indicating the presence of a stable 
modulation, chronic and therefore probably at the genomic 
level. 
Whereas some of tumor tissue cells have the 
ability to proliferate and form new tumors, results, such 
as inhibition of clonogenic capacity along with the 
recovery of cellular viability loss after the withdrawal 
of the treatment could minimize the probability of tumor 
recurrence and, therefore, have significant implications 
for the development of therapeutic strategies for the tumor 
studied.
The study of the mechanism of cell death induced 
by the treatment used is also a highly relevant criterium. 
Apoptosis was primarily described as a series of cellular 
morphological changes that occur in the absence of 
inflammation, but has been redefined on the basis of 
molecular events that can be initiated through an extrinsic 
pathway or by an intrinsic pathway triggered by leakage 
of cytochrome c from mitochondria and activation of 
caspases (Budihardjo et al., 1999).
The most important morphological feature of 
apoptosis is the condensation of chromatin and it has 
been assumed that this may reflect the oligonucleosomal 
fragmentation pattern (Wyllie, 1992). In our results, the 
analysis of nuclear morphology by using fluorescent 
dye Hoechst® 33258 revealed a greater chromatin 
condensation in the treated cells, patterns consistent 
with apoptotic cell death. Moreover, the data obtained 
through flow cytometry and double staining for annexin 
V/ propidium iodide showed a predominantly cell death 
by apoptosis in the SiHa cells treated with the E. uniflora 
aqueous crude extract for 48 hours.
Thus, based on the results described herein we can 
conclude that the aqueous crude extract of E. uniflora is 
able to change significantly both the viability of human 
cervical cancer cells, such as migration ability, adhesion, 
formation of colonies and recovery capacity after 
withdrawal of the treatment, without altering the viability 
of non-tumor cells. All this information plus the finding 
of an apoptosis mediated cell death, suggest a potential 
antineoplastic effect of the plant extract. However, more 
studies are indeed needed for the identification of the 
compounds responsible for the biological effects observed 
here, as well as clinical trials to study its potential as a new 
therapeutic alternative for human cervical cancer.
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